BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/12/2014 1:58:00 PM | Browse: 717 | Download: 634
Publication Name World Journal of Rheumatology
Manuscript ID 10603
Country/Territory United Kingdom
Received
2014-04-09 10:01
Peer-Review Started
2014-04-09 19:28
To Make the First Decision
2014-06-06 10:58
Return for Revision
2014-06-10 09:01
Revised
2014-06-21 03:40
Second Decision
2014-07-29 09:39
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-07-29 09:57
Articles in Press
2014-07-29 09:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-09-03 17:46
Publish the Manuscript Online
2014-09-12 13:58
ISSN 2220-3214 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Rheumatology
Manuscript Type Observational Study
Article Title Monitoring osteoporosis therapy: Can FRAX help assessing success or failure in achieving treatment goals?
Manuscript Source Invited Manuscript
All Author List Yasser El Miedany, Maha El Gaafary, Ahmed El Yassaki, Sally Youssef, Annie Nasr and Ihab Ahmed
Funding Agency and Grant Number
Corresponding Author Yasser El Miedany, MD, FRCP, Consultant Rheumatologist, Darent Valley Hospital, Dartford, Kent, DA2 8DA, United Kingdom. miedanycrd@yahoo.com
Key Words The World Health Organization fracture risk assessment tool; Osteoporosis; Fracture; Dual-energy X-ray absorptiometry
Core Tip Treatment of osteoporosis should assure that the patient benefits from the treatment without experiencing undue harm. Monitoring of patients treated for osteoporosis has been recommended and so far dual-energy X-ray absorptiometry has been recognized as the tool to monitor osteoporosis therapy by several clinical practice guidelines. Recently, the duration of osteoporosis therapy became a research question with the possibility of having a drug holiday. However, more research is still needed to adequately assess when to stop the osteoporosis therapy and what is the optimal duration of the drug holiday. This work was carried out aiming at determining whether the World Health Organization fracture risk assessment tool can be used as a tool to monitor patients receiving osteoporosis treatment and to evaluate its ability to predict new low trauma fractures.
Publish Date 2014-09-12 13:58
Citation El Miedany Y, El Gaafary M, El Yassaki A, Youssef S, Nasr A, Ahmed I. Monitoring osteoporosis therapy: Can FRAX help assessing success or failure in achieving treatment goals? World J Rheumatol 2014; 4(2): 14-21
URL http://www.wjgnet.com/2220-3214/full/v4/i2/14.htm
DOI http://dx.doi.org/10.5499/wjr.v4.i2.14
Full Article (PDF) WJR-4-14.pdf
Full Article (Word) WJR-4-14.doc
Manuscript File 10603-Review.docx
Answering Reviewers 10603-Answering reviewers.pdf
Copyright License Agreement 10603-Copyright assignment.pdf
Peer-review Report 10603-Peer review(s).pdf
Scientific Misconduct Check 10603-CrossCheck.jpg
Scientific Editor Work List 10603-Scientific editor work list.pdf